Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
AstraZeneca
McKinsey
Mallinckrodt
Merck

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017854

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 017854 describes REGLAN, which is a drug marketed by West-ward Pharms Int, Robins Ah, Ani Pharms, and Meda Pharms, and is included in four NDAs. It is available from one supplier. Additional details are available on the REGLAN profile page.

The generic ingredient in REGLAN is metoclopramide hydrochloride. There are fourteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
Summary for 017854
Tradename:REGLAN
Applicant:Ani Pharms
Ingredient:metoclopramide hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 017854
Mechanism of ActionDopamine D2 Antagonists
Medical Subject Heading (MeSH) Categories for 017854
Suppliers and Packaging for NDA: 017854
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
REGLAN metoclopramide hydrochloride TABLET;ORAL 017854 NDA ANI Pharmaceuticals, Inc. 62559-165 62559-165-01 100 TABLET in 1 BOTTLE, PLASTIC (62559-165-01)
REGLAN metoclopramide hydrochloride TABLET;ORAL 017854 NDA ANI Pharmaceuticals, Inc. 62559-166 62559-166-01 100 TABLET in 1 BOTTLE, PLASTIC (62559-166-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:May 5, 1987TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Harvard Business School
Moodys
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.